Acadia Trust’s Novartis NVS Stock Holding History

Acadia Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$3.51M	Buy	49,565 +2,349	+5%	+$171K	1.06%	40
2016 Q2	$3.49M	Buy	+47,216	New	+$3.26M	1.07%	39
2013 Q4	–	Sell	-94,156	Closed	-$6.47M	–	78
2013 Q3	$6.47M	Sell	94,156 -282	-0.3%	-$18.7K	2.78%	20
2013 Q2	$5.98M	Buy	+94,438	New	+$6.14M	2.66%	22

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Acadia Trust's NVS Position: Q3 2016 in Review

Acadia Trust increased its Novartis (NVS) stake by 5% in Q3 2016, buying an estimated $171K and bringing the position to 49,565 shares worth $3.51M. The position accounts for 1.06% of the portfolio, ranked #40.

Acadia Trust first reported a position in NVS in Q2 2013 and has held it in 4 quarters since. The position peaked at $6.47M in Q3 2013. 877 funds tracked by Wall St. Rank hold NVS as of Q3 2016.

Acadia Trust held 49,565 shares of Novartis worth $3.51M as of Q3 2016.
Acadia Trust bought 2,349 Novartis shares in Q3 2016, an estimated $171K.
Novartis made up 1.06% of Acadia Trust's portfolio in Q3 2016, its #40 holding.
Acadia Trust first reported a position in Novartis in Q2 2013 and has held it in 4 quarters since.
Acadia Trust's Novartis position peaked at $6.47M in Q3 2013.
877 funds tracked by Wall St. Rank held Novartis as of Q3 2016.

Based on Acadia Trust's 13F filing for Q3 2016, filed 15 Nov 2016.